Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Bismuth-containing Quadruple Therapy for First Line Helicobacter Pylori Eradication: A Multicenter Retrospective Study

NCT07167511 is registered in ClinicalTrials.gov with Yueyue Li as lead sponsor.

NCT NCT07167511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07167511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Bismuth-containing Quadruple Therapy for First Line Helicobacter Pylori Eradication: A Multicenter Retrospective Study
Lead sponsor
Yueyue Li
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
July 31, 2025
Enrollment
1,730 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection